Lymphocyte kinetics and precursor frequency-dependent recovery of CD4+CD45RA+CD62L+ naive T cells following triple-drug therapy for HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 15, Issue 5, 1999, Pages 435-443

  Hengel, Richard L ^a,b,c   Jones, Bonnie M ^b   Kennedy, M Susan ^b   Hubbard, Marjorie R ^b   McDougal, J Steven ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; VIRUS RNA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CYTOMETRY; FOLLOW UP; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; MEMORY; MORBIDITY; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD45; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; L-SELECTIN; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RNA, VIRAL; T-LYMPHOCYTE SUBSETS;

EID: 0033586392     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311187     Document Type: Article

References (26)

1. Lifson AR, Rutherford GW, and Jaffe HW: The natural history of human immunodeficiency virus infection. J Infect Dis 1988;158: 1360-1367.
2. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, and Shearer GM: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-1019.
3. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA, and Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-2066.
4. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, and Terstappen LW: Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol 1993;150:1105-1121.
5. Kansas GS: Selectins and their ligands: Current concepts and controversies. Blood 1996;88:3259-3287.
6. + memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-6062.
7. Woods TC, Roberts BD, Butera ST, and Folks TM: Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells. Blood 1997;89:1635-1641.
8. Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JM, Baseler M, Lloyd AL, Nowak MA, and Fauci AS: Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 1997;94:13193-13197.
9. Wallace DL and Beverley PC: Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 1990;69:460-467.
10. Centers for Disease Control (CDC): Update: Trends in AIDS incidence - United States, 1996. MMWR 1997;46:861-867.
11. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ, Feinberg JE, Balfour HH, Dayton LR, Chodakewitz JA, and Fischl MA: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.
12. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, and Chodakewitz JA: Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337:734-739.
13. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, and Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
14. Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama, Debre P, and Leibowitch J: Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
15. Pakker NG, Notermans DW, DeBoer RJ, Roos MTL, De Wolf F, Hill A, Leonard JM, Danner SA, Miedema F, and Schellekens PTA: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med 1998;4:208-214.
16. Silvestri G, Munoz-Calleja C, Bagnarelli P, Piedimonte G, Clementi M, and Montroni M: Early increase of CD4+CD45RA+ and CD4+CD95 - cells with conserved repertoire induced by antiretroviral therapy in HIV-infected patients. J Exp Immunol 1998; 111:3-11.
17. Connors M, Kovacs JA, Krevat S, Geabanacloche JC, Sneller MC, Flanigan M, Metcalf JA, Walker RE, Falloon J, Baseler M, Stevens R, Feuerstein I, Masur H, and Lane HC: HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med 1997;3:533-540.
18. Centers for Disease Control (CDC): 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR 1998;46(RR-2):1-34.
19. Michie CA, McLean A, Alcock C, and Beverley PC: Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature (London) 1992;360:264-265.
20. Reddy MM, Goetz RR, Gorman JM, Grieco MH, Chess L, and Lederman S: Human immunodeficiency virus type-1 infection of homosexual men is accompanied by a decrease in circulating B cells. J Acquir Immune Defic Syndr 1991;4:428-434.
21. Kaufmann D, Pantaleo G, Sudre P, Telenti A, and the Swiss HIV Cohort Study: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 1998;351:723-724.
22. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, and Steinberg SM: Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
23. Tough DF and Sprent J: Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127-1135.
24. Bell EB and Sparshott SM: Interconversion of CD45R subsets of CD4 T cells in vivo. Nature (London) 1990;348:163-166.
25. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Decks S, and McCune JM: Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Med 1999;5:83-89.
26. Zhang ZQ, Notermans DW, Sedgewick G, Cavert W, Wietgrefe S, Zupancic M, Gebhard K, Henry K, Boies L, Chen Z, Jenkins M, Mills R, McDade H, Goodwin C, Schuwirth CM, Danner SA, and Haase AT: Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci USA 1998;95:1154-1159.